-
In 2004 biotech firm Amgen began trials of a Parkinson's drug called glial cell line-derived neurotrophic factor, or GDNF.
FORBES: Magazine Article
-
"We've investigated a number of accidents where there were distractions, " she said, adding that it's unknown whether cell phone use was a factor in this crash.
CNN: Investigator: D.C. Metro crash 'a scene of real devastation'
-
In 2004 biotech firm Amgen (nasdaq: AMGN - news - people ) began trials of a Parkinson's drug called glial cell line-derived neurotrophic factor, or GDNF.
FORBES: On The Cover/Top Stories
-
On Thursday, the company announced on its blog that so-called two-factor authentication via cell phone is now available for all users logging into Google apps like Gmail and Google Docs, not just the business accounts that gained the feature last September.
FORBES: Google Adds Cellphone-Based Security For Everyone
-
High density areas served by a large number of cell sites might not be an issue in urban locations, but it will factor in a great deal once you are traveling into and around rural areas not served by a vast number of sites.
FORBES: All-Aluminum iPhone In The Works?
-
Lapatinib, it turns out, also inhibits the activity of a protein called the epidermal growth factor receptor, which has been found to be important for stem-cell proliferation.
ECONOMIST: Cancer therapy
-
The scientists found that a cell-signaling protein, or cytokine, known as a hippocampal TNF (tumor necrosis factor) played a limited role.
CNN: Unplug! Too much light at night may lead to depression
-
She said they were currently funding research into drugs that mimic the action of nerve growth factor (NGF), the name given to the gene therapy involving stimulating cell function.
BBC: NEWS | Health | Alzheimer's gene therapy hailed